Infinite Revival LLC offers a one of a kind medical weight loss program that provides individualized plans to accommodate every person’s body, lifestyle and goals. We offer a well-rounded program by our team of professionals consisting of a Nurse Practitioner, Registered Dietitian and Personal Trainer who work together to focus on the well being of the whole person.
We have multiple program options to choose from. For best long lasting results we recommend the All Inclusive Package to assure you are losing fat mass, not lean body mass to avoid weight fluctuations and lower metabolism.
Increased energy, decreased cholesterol levels, lowered blood pressure, improved heart health, decreased joint pain, enhanced physical performance, improved mental clarity.
Semaglutide
GLP-1 receptor agonist medication that is used for diabetes type 2, but has been found to have assisted with weight loss. It helps with weight loss by mimicking the action of a hormone that helps regulate blood sugar levels, increasing insulin secretion, reducing glucagon release, slows gastric emptying, and promotes the feeling of fullness or satiety.
It has been a popular choice for weight loss goals by taking a once a week injection that can be self administered or administered by a licensed professional.
Side effects include and not limited to: nausea, vomiting, diarrhea, abdominal pain, constipation, hypoglycemia, dyspepsia, abdominal distension, GERD, flatulence, gastritis, elevated liver enzymes, can cause abnormal renal function, injection site sensitivities (redness, bruising, tenderness).
Tirzepatide
Dual GLP-1 and GIP receptor agonist. Used for type 2 diabetes and weight loss. It activates two key hormones involved in glucose regulation and appetite control. It helps to improve insulin secretion, reduce appetite which helps with weight loss.
Less side effects due to the dual agonist receptors.
Once a week injections that can be self-administered or weekly by a licensed professional.
Side effects include but not limited to: nausea, diarrhea, appetite decrease, tachycardia, vomiting, constipation, dyspepsia, abdominal pain, injection site sensitivities (redness, bruising, tenderness), flatulence, GERD, elevated liver enzymes, pancreatitis, acute kidney injury.
Adults with body mass index (BMI) of 30 or greater, or BMI of 27 or higher with at least one weight related health conditions (diabetes type 2, hypertension).
Type 1 diabetes, pregnancy or breastfeeding, GI disease, history of pancreatitis or high risk of pancreatitis, history of medullary thyroid cancer or multiple endocrine neoplasia (MEN) type 2, or kidney disease.